CClinicalTrials.gg
Sign In
RecruitingNCT05447247Updated Jun 18, 2023

Clinical Study on Treatment of Neurogenic Bladder by Electroacupuncture on Ba Liao Point Under Ultrasound Guidance

An interventional study of Acupuncturing Ba Liao point under ultrasound guidance in To Investigate the Clinical Effect of Acupuncturing Ba Liao for Neurogenic Bladder Under the Guidance of Ultrasound, sponsored by Qilu Hospital of Shandong University. Recruiting at 1 site in China. Per ClinicalTrials.gov, last updated 2023-06-18.

Sponsored by Qilu Hospital of Shandong University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Oct 2023, 2 years 11 months ago, but the record still lists the study as recruiting.
  • Started Jun 2022; still recruiting 4 years 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
114
Allocation
Randomized
Sex
All
01

Study summary

To explore acupuncture under the premise of real-time, dynamic and accurate positioning of Ba liao point with ultrasound, observe the clinical efficacy of treating neurogenic bladder, clarify the essence of acupoints, and provide a new method for the standardization of acupuncture and moxibustion.

02

Conditions studied

  • To Investigate the Clinical Effect of Acupuncturing Ba Liao for Neurogenic Bladder Under the Guidance of Ultrasound
03

In context

Urinary Bladder, Neurogenic

185 studies on the registry are indexed under Urinary Bladder, Neurogenic; 40 are open to participants now.

This study's planned enrollment of 114 is above the median of 36 across 124 interventional studies indexed under Urinary Bladder, Neurogenic.

Browse Urinary Bladder, Neurogenic studies →

Lead sponsor

Qilu Hospital of Shandong University is the lead sponsor of 299 studies on the registry; 181 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. The diagnosis of neurogenic bladder conforms to the main points;
  2. Symptoms and signs: patients with lower urinary tract dysfunction such as frequency of urination, urgency of urination, inadequacy of urine or retention of urine, urinary incontinence; Physical examination showed paresthesia in perineum and saddle area.
  3. Auxiliary examination; Routine urine examination, B - ultrasonography of urinary system and urodynamic examination.
  4. Indwelling catheter has been removed;
  5. Conscious and able to accurately express symptoms and signs;
  6. Patients who inform patients and their families of the research situation in detail and obtain their consent for treatment.

Exclusion criteria

-

Exclusion Criteria:

  1. Lower urinary tract dysfunction caused by non-nervous system factors such as urethral calculi and organic obstruction;
  2. patients with serious heart and lung diseases, liver and hematopoietic diseases and mental diseases;
  3. patients with prostate cancer, urethral stricture, bladder neck fibrosis, interstitial cystitis, glandular cystitis and other diseases;
  4. patients implanted with urethral stents or sacral nerve electrodes;
  5. pregnant and lactation women;
  6. Fear of acupuncture, needle-sickness and blood sickness. -
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
114 participants (estimated)

Study arms

  • Experimental
    Acupuncturing Ba Liao point under ultrasound guidance

    Other: Acupuncturing Ba Liao point under ultrasound guidance

  • Experimental
    Conventional acupuncture

    Other: Acupuncturing Ba Liao point under ultrasound guidance

Interventions

  • OtherAcupuncturing Ba Liao point under ultrasound guidance

    Acupuncturing Ba Liao point under ultrasound guidance

06

What researchers measure

Primary outcomes

  1. Urodynamic study

    Residual urine volume, maximum urine flow rate, average urine flow rate, urination time, urine flow time and urine flow rate were assessed

    Time frame: Once every two weeks:Before treatment, two weeks after treatment, four weeks after treatment

  2. Neurogenic bladder symptom score

    Patients were evaluated for neurogenic bladder symptoms

    Time frame: Once every two weeks:Before treatment, two weeks after treatment, four weeks after treatment.followed up for 3 months after treatment

07

Study locations

1 of 1 sites recruiting
  • Qilu Hospital of Shandong University
    Jinan, Shandong 250001, China
    • Yang Zhang, Doctor · Contact · +86-18560083582
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05447247
Lead sponsor
Qilu Hospital of Shandong University
Responsible party
Sponsor
First posted
Jul 7, 2022
Start date
Jun 1, 2022
Primary completion
Oct 30, 2023 (estimated)
Completion
Dec 30, 2023 (estimated)
Last update
Jun 18, 2023

Study contacts

Yijun Du, Master
Contact
duyijun.19871006@163.com
+86-18560083602

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Urinary Bladder, Neurogenic→

Other studies from this sponsor

Qilu Hospital of Shandong University

Start the discussion